Digital therapy maker Health promotion is working with a pharmaceutical company that focuses on neuroscience Biogen on a digital interactive and educational platform for multiple sclerosis.
The product will include Happify’s community for people living with MS, as well as access to neurological service providers such as doctors and nurses, mental health professionals, nutritionists and rehabilitation specialist. Biogen will contribute educational content and patient care resources.
“This partnership is one of many ways in which we’re focused on supporting patients by seeing them where they are. The combination of Biogen’s expertise in neuroscience and our commitment to it. for digital health, along with Happify Health’s AI and digital treatment capabilities, will help foster a holistic connection and experience that allows patients to feel supported throughout their journey. ,” Jason Hawbecker, head of strategic partnerships and partnerships at Biogen, said in a statement.
“We are excited about the potential of this partnership to provide total support to the MS community.”
WHY IT IMPORTANT
Follow National Multiple Sclerosis Associationnearly a million people have MS in the U.S. This disease can cause symptom such as numbness or tingling, weakness, difficulty walking, vision problems, and dizziness.
Happify is introducing the partnership as a way to improve patients’ journey of care and keep them informed about their condition.
Ofer Leidner, president of Happify Health, said: “It can be a challenge for people living with MS to stay up to date with the latest treatments, explain new symptoms or investigate changes changes in their health may or may not be related to MS,” said in a statement.
“We are providing the MS community with a solution configured to meet their specific needs, as well as the opportunity to interact with experts, receive curated content, and discuss on disease management with other members of the community. We are excited to partner with Biogen on this opportunity. Their leadership in the MS space.”
TREND TO BIGGER WOMAN
Happify has had a partnership in recent months. Earlier this month, digital therapy company announced a partnership focuses on women’s health with insurance company Anthem, which will soon be renamed Elevance Health.
In March, Happened enter into an agreement with healthcare and pharmaceutical company Zuellig Pharma to commercialize two of its digital prescription therapies in Asia.
Launch is also recent launch a digital program for people with psoriasis in Spain, Italy and the UK in partnership with Barcelona-based pharmaceutical company Almirall. Happify also plays a $73 million Series D funding round in March 2021.
Biogen is also not new to the digital health space. In May, it enter into a license agreement with prescription digital therapy startup MedRhythm to develop and commercialize the product MR-004, which aims to improve mobility for people with multiple sclerosis.
